Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03011295
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
DPS | 3-(1H-INDOL-3-YL)-2-[4-(4-PHENYL- PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]- PROPIONIC ACID | A | 1CAQ | 0.75 | |
DPS | 3-(1H-INDOL-3-YL)-2-[4-(4-PHENYL- PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]- PROPIONIC ACID | A | 1CIZ | 0.75 | |
STU | STAUROSPORINE | A,B | 3CBL | 0.72 | |
STU | STAUROSPORINE | A | 1QPJ | 0.72 | |
STU | STAUROSPORINE | A,B | 3CD3 | 0.72 | |
STU | STAUROSPORINE | A | 2ITU | 0.72 | |
STU | STAUROSPORINE | A,B | 2BUJ | 0.72 | |
STU | STAUROSPORINE | A,B | 2CLQ | 0.72 | |
STU | STAUROSPORINE | A | 1XBC | 0.72 | |
STU | STAUROSPORINE | A | 2ITW | 0.72 | |
STU | STAUROSPORINE | A | 1E8Z | 0.72 | |
STU | STAUROSPORINE | A | 1YHS | 0.72 | |
STU | STAUROSPORINE | A,B | 3D7T | 0.72 | |
STU | STAUROSPORINE | A | 1QPD | 0.72 | |
STU | STAUROSPORINE | A | 2Z7R | 0.72 | |
STU | STAUROSPORINE | A,B,C,D | 2NRY | 0.72 | |
STU | STAUROSPORINE | A | 1U59 | 0.72 | |
STU | STAUROSPORINE | A | 1NVR | 0.72 | |
STU | STAUROSPORINE | A,B,C,D | 2OIC | 0.72 | |
STU | STAUROSPORINE | A | 1AQ1 | 0.72 | |
STU | STAUROSPORINE | A | 1BYG | 0.72 | |
STU | STAUROSPORINE | A,B | 1SM2 | 0.72 | |
STU | STAUROSPORINE | X | 2DQ7 | 0.72 | |
STU | STAUROSPORINE | A | 3CKX | 0.72 | |
STU | STAUROSPORINE | A,B | 1Q3D | 0.72 | |
STU | STAUROSPORINE | E | 1STC | 0.72 | |
STU | STAUROSPORINE | A | 1OKY | 0.72 | |
STU | STAUROSPORINE | A | 1WVY | 0.72 | |
STU | STAUROSPORINE | A | 2HW7 | 0.72 | |
STU | STAUROSPORINE | A,B | 1SNU | 0.72 | |
STU | STAUROSPORINE | A | 2ITQ | 0.72 | |
STU | STAUROSPORINE | A,B,C,D | 1NXK | 0.72 | |
STU | STAUROSPORINE | A | 3BKB | 0.72 | |
STU | STAUROSPORINE | A | 1XJD | 0.72 | |
STU | STAUROSPORINE | A | 3FME | 0.72 | |
STU | STAUROSPORINE | A,B | 2GCD | 0.72 | |
STU | STAUROSPORINE | A,B,C | 2PZY | 0.72 | |
7HI | (3R,5R)-7-[3-(biphenyl-4-ylcarbamoyl)- 2-ethyl-5,6,7,8-tetrahydrocyclohepta[b]pyrrol- 1(4H)-yl]-3,5-dihydroxyheptanoic acid | A,B,C,D | 3CD5 | 0.7 | |
IID | N-(1-ISOPROPYLPIPERIDIN-4-YL)-1- (3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE | A,B | 2BQ7 | 0.71 | |
8CA | 9-benzyl-2,3,4,9-tetrahydro-1H- carbazole-8-carboxylic acid | A | 3FR2 | 0.71 | |
JTP | N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2- D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]- 2-METHYL-L-ALANINE | A,B | 2DXS | 0.72 | |
2S8 | (2S)-8-[(tert-butoxycarbonyl)amino]- 2-(1H-indol-3-yl)octanoic acid | B | 3C6N | 0.71 | |
SBR | (R)-N-(3-INDOL-1-YL-2-METHYL-PROPYL)- 4-SULFAMOYL-BENZAMIDE | A | 1IF7 | 0.76 | |
NSI | 3-(4-METHOXYPHENYL)-N-(PHENYLSULFONYL)- 1-[3-(TRIFLUOROMETHYL)BENZYL]-1H- INDOLE-2-CARBOXAMIDE | A | 2HFP | 0.75 | |
RSS | 5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA- 12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)- HEXANOIC ACID | A,B | 1MMP | 0.72 | |
882 | (3R,5R)-7-[5-(ANILINOCARBONYL)- 3,4-BIS(4-FLUOROPHENYL)-1-ISOPROPYL- 1H-PYRROL-2-YL]-3,5-DIHYDROXYHEPTANOIC ACID | A,C,D | 2Q1L | 0.71 | |
882 | (3R,5R)-7-[5-(ANILINOCARBONYL)- 3,4-BIS(4-FLUOROPHENYL)-1-ISOPROPYL- 1H-PYRROL-2-YL]-3,5-DIHYDROXYHEPTANOIC ACID | A,C,D | 3CD7 | 0.71 | |
839 | 3-(9-HYDROXY-1,3-DIOXO-4-PHENYL- 2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL- 6(1H)-YL)PROPANOIC ACID | A | 2IN6 | 0.71 | |
KAW | N-{(5S)-4,4-dihydroxy-6-phenyl- 5-[(phenylcarbonyl)amino]hexanoyl}- L-tryptophan | A | 3BKL | 0.76 | |
4ST | 1,2,3,4-TETRAHYDROGEN-STAUROSPORINE | A | 2J0J | 0.72 | |
4ST | 1,2,3,4-TETRAHYDROGEN-STAUROSPORINE | B | 2J0M | 0.72 | |
4ST | 1,2,3,4-TETRAHYDROGEN-STAUROSPORINE | A,B | 2J0K | 0.72 | |
4ST | 1,2,3,4-TETRAHYDROGEN-STAUROSPORINE | A | 1YVJ | 0.72 | |
4ST | 1,2,3,4-TETRAHYDROGEN-STAUROSPORINE | A,B,C | 2HZ4 | 0.72 | |
9HI | (3R,5R)-7-{3-[(4-carbamoylphenyl)sulfamoyl]- 4,5-bis(4-fluorophenyl)-2-(1-methylethyl)- 1H-pyrrol-1-yl}-3,5-dihydroxyheptanoic acid | A,C,D | 3CDB | 0.72 | |
ZAM | 3-[(ACETYL-METHYL-AMINO)-METHYL]- 4-AMINO-N-METHYL-N-(1-METHYL-1H- INDOL-2-YLMETHYL)-BENZAMIDE | A,B | 1LX6 | 0.71 | |
ZY4 | N-[(1S)-1-BENZYL-2,2-DIHYDROXY- 3-(TETRAHYDRO-2H-PYRAN-4-YLAMINO)PROPYL]- 6-ETHYL-1-METHYL-1,3,4,6-TETRAHYDRO[1,2]THIAZEPINO[5,4,3- CD]INDOLE-8-CARBOXAMIDE 2,2-DIOXIDE | A | 2WF4 | 0.75 | |
CMI | 1-(3-CARBAMIMIDOYL-BENZYL)-4-METHYL- 1H-INDOLE-2-CARBOXYLIC ACID 3,5- DIMETHYL-BENZYLAMIDE | B | 1LQD | 0.72 | |
WAC | N-{3-[(12bS)-7-oxo-1,3,4,6,7,12b- hexahydroindolo[2,3-a]quinolizin- 12(2H)-yl]propyl}propane-2-sulfonamide | B | 1S1S | 0.76 | |
KSA | K-252A | A | 1R0P | 0.7 | |
KSA | K-252A | A | 3EQF | 0.7 | |
T19 | PHENYLMETHYLENECARBOXY-(METHYLENEAMINO- FORMYL-DIPHENYLMETHYL)METHY-PRO- BOROVAL | H,I | 1AIX | 0.71 | |
117 | 7-[2-(4-FLUORO-PHENYL)-5-ISOPROPYL- 3-PHENYL-4-PHENYLCARBAMOYL-PYRROL- 1-YL]- 3,5-DIHYDROXY-HEPTANOIC ACID | A,B,C,D | 1HWK | 0.72 | |
POO | 3-CYCLOHEXYL-1-(2-{METHYL[(1-METHYLPIPERIDIN- 3-YL)METHYL]AMINO}-2-OXOETHYL)- 2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID | A | 2BRL | 0.75 | |
P5B | N-(ETHYLSULFONYL)TRYPTOPHYL-N~1~- {4-[AMINO(IMINO)METHYL]BENZYL}GLUTAMAMIDE | H,L | 1WUN | 0.7 | |
CM7 | N-[(1S,2R)-1-benzyl-2-hydroxy-3- {[3-(trifluoromethyl)benzyl]amino}propyl]- 7-ethyl-1-methyl-3,4-dihydro-1H- [1,2,5]thiadiazepino[3,4,5-hi]indole- 9-carboxamide 2,2-dioxide | A | 2VNN | 0.72 | |
8HI | (3R,5R)-7-{3-(4-fluorophenyl)-1- (1-methylethyl)-4-phenyl-5-[(4- sulfamoylphenyl)carbamoyl]-1H-pyrrol- 2-yl}-3,5-dihydroxyheptanoic acid | A,B,C,D | 3CDA | 0.76 | |
6IN | 4-(1-BENZYL-3-CARBAMOYLMETHYL-2- METHYL-1H-INDOL-5-YLOXY)-BUTYRIC ACID | A | 1DB5 | 0.71 | |
IMA | [4-({[5-BENZYLOXY-1-(3-CARBAMIMIDOYL- BENZYL)-1H-INDOLE-2-CARBONYL]-AMINO}- METHYL)-PHENYL]-TRIMETHYL-AMMONIUM | B | 1LPG | 0.71 | |
IMA | [4-({[5-BENZYLOXY-1-(3-CARBAMIMIDOYL- BENZYL)-1H-INDOLE-2-CARBONYL]-AMINO}- METHYL)-PHENYL]-TRIMETHYL-AMMONIUM | A | 1LQE | 0.71 | |
OAI | 6-(OXALYL-AMINO)-1H-INDOLE-5-CARBOXYLIC ACID | A | 1C83 | 0.71 | |
IMS | 2-[1-(4-CHLOROBENZOYL)-5-METHOXY- 2-METHYL-1H-INDOL-3-YL]-N-[(1S)- 1-(HYDROXYMETHYL)PROPYL]ACETAMIDE | P | 2OYU | 0.7 | |
IM8 | 2-[1-(4-CHLOROBENZOYL)-5-METHOXY- 2-METHYL-1H-INDOL-3-YL]-N-[(1R)- 1-(HYDROXYMETHYL)PROPYL]ACETAMIDE | P | 2OYE | 0.7 | |
274 | (3Z)-N-(3-CHLOROPHENYL)-3-({3,5- DIMETHYL-4-[(4-METHYLPIPERAZIN- 1-YL)CARBONYL]-1H-PYRROL-2-YL}METHYLENE)- N-METHYL-2-OXOINDOLINE-5-SULFONAMIDE | A | 2J7T | 0.72 | |
GSQ | 5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL- 2-MORPHOLIN-4-YL-2-5-CHLORO-N-{(3S)- 1-[(1S)-1-METHYL-2-MORPHOLIN-4- YL-2-SULFONAMIDE | A | 2J2U | 0.71 | |
TCR | CYCLOMETHYLTRYPTOPHAN | A | 3AIG | 0.71 | |
TRF | N1-FORMYL-TRYPTOPHAN | A,B | 1VRK | 0.7 | |
TRF | N1-FORMYL-TRYPTOPHAN | A,B,C,D | 1QS7 | 0.7 | |
TUO | 2-(hydrazinocarbonyl)-3-phenyl- 1H-indole-5-sulfonamide | A | 3B4F | 0.71 | |
FRN | A | 2CV3 | 0.7 | ||
CMM | 2-[2-(1-CARBAMIMIDOYL-PIPERIDIN- 3-YL)-ACETYLAMINO]-3-{4-[2-(3-OXALYL- 1H-INDOL-7-YL)ETHYL]-PHENYL}-PROPIONIC ACID METHYL ESTER | A,B | 1M49 | 0.76 | |
3CS | 3-[3-(3,3-DIMETHYLBUTANOYL)-1-(4- IODOBENZYL)-5-(QUINOLIN-2-YLMETHOXY)- 1H-INDOL-2-YL]-2,2-DIMETHYLPROPANOIC ACID | A,B,C,D,E,F | 2Q7R | 0.7 | |
C80 | (2S,4S,5R,7R)-4-AMINO-8-(BUTYLAMINO)- 5-HYDROXY-2,7-DIMETHYL-8-OXOOCTYL 1- BENZYL-1H-INDOLE-3-CARBOXYLATE | C,O | 2V11 | 0.74 | |
SNX | 2-[(2-methoxyethyl)amino]-4-(4- oxo-1,2,3,4-tetrahydro-9H-carbazol- 9-yl)benzamide | A | 3D0B | 0.77 | |
110 | 3-(4-AMINO-CYCLOHEXYL)-2-HYDROXY- 3-[(4-OXO-2-PHENYLMETHANESULFONYL- 1,2,3,4-TETRAHYDRO-PYRROLO[1,2- A]PYRAZINE-6-CARBONYL)-AMINO]-PROPIONIC ACID BUTYL ESTER | A | 1G37 | 0.77 | |
I4A | 5-(3-carbamoylbenzyl)-5,6,7,8,9,10- hexahydrocyclohepta[b]indole-4- carboxylic acid | A | 3FR5 | 0.71 | |
567 | 2-[[(2R)-1-[[(2S)-5-amino-1-[(4- carbamimidoylphenyl)methylamino]- 1,5-dioxo-pentan-2-yl]amino]-3- (1H-indol-3-yl)-1-oxo-propan-2- yl]sulfamoyl]ethanoic acid | H,L | 2ZWL | 0.71 | |
K88 | (3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7- TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)- 2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE | A,D | 2WEL | 0.71 | |
F8A | 9-[2-(trifluoromethyl)benzyl]-2,3,4,9- tetrahydro-1H-carbazole-8-carboxylic acid | A | 3FR4 | 0.71 | |
SBS | (S)-N-(3-INDOL-1-YL-2-METHYL-PROPYL)- 4-SULFAMOYL-BENZAMIDE | A | 1IF8 | 0.76 | |
UCN | 7-HYDROXYSTAUROSPORINE | A | 1OKZ | 0.71 | |
UCN | 7-HYDROXYSTAUROSPORINE | A,C | 1PKD | 0.71 | |
UCN | 7-HYDROXYSTAUROSPORINE | A | 1NVQ | 0.71 | |
6MR | N-[(4'-IODOBIPHENYL-4-YL)SULFONYL]- D-TRYPTOPHAN | A,B | 2OW0 | 0.76 | |
792 | N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}- 5-methyl-D-tryptophan | A,B,C,D | 3G42 | 0.71 | |
CMF | 3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL- 2-OXOETHYL)-2-PHENYL-1H-INDOLE- 6-CARBOXYLIC ACID | A | 2BRK | 0.78 | |
LI3 | 3-FLUORO-N-1H-INDOL-5-YL-5-MORPHOLIN- 4-YLBENZAMIDE | A | 1WBV | 0.7 | |
SBB | N-[2-(1H-INDOL-5-YL)-BUTYL]-4-SULFAMOYL- BENZAMIDE | A | 1IF9 | 0.75 | |
LI2 | 3-FLUORO-5-MORPHOLIN-4-YL-N-[3- (2-PYRIDIN-4-YLETHYL)-1H-INDOL- 5-YL]BENZAMIDE | A | 1WBS | 0.7 | |
359 | 3-[[3-[(2R)-3-[[(2S)-5-amino-1- [(4-carbamimidoylphenyl)methylamino]- 1,5-dioxo-pentan-2-yl]amino]-2- (ethylsulfonylamino)-3-oxo-propyl]- 1H-indol-5-yl]oxymethyl]benzoic acid | H,L | 2ZZU | 0.71 | |
CBB | 1-(3-CARBAMIMIDOYL-BENZYL)-1H-INDOLE- 2-CARBOXYLIC ACID 3-CARBAMIMIDOYL- BENZYLESTER | B | 1LPK | 0.74 | |
5PI | N-(ETHYLSULFONYL)-5-PROPOXY-L-TRYPTOPHYL- N~1~-{4-[AMINO(IMINO)METHYL]BENZYL}- L-GLUTAMAMIDE | H,L | 1WV7 | 0.7 |